Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Schedule of Analyst Institutional Investor Meetings 30th Aug 2021 Scrutinizer report of the 85th Annual General Meeting 26th Aug 2021 Proceedings of the 85th Annual General Meeting 25th Aug 2021 Press Release - Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars 25th Aug 2021 Agreement with Kemwell Biopharma for Incorporation of a Joint Venture Company 25th Aug 2021 Schedule of Analyst Institutional Investor Meeting 23rd Aug 2021 Schedule of Analyst Institutional Investor Meetings 19th Aug 2021 Allotment of 8,668 equity shares under ESOS 2013-A 17th Aug 2021 Schedule of Analyst Institutional Investor Meeting 16th Aug 2021 Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%) 12th Aug 2021 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
